Literature DB >> 7051998

Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer.

A P Forrest, H J Stewart, M M Roberts, R J Steele.   

Abstract

Axillary node sampling was introduced as a means of defining those patients whose primary breast cancer was treated by simple mastectomy in whom postoperative radiotherapy could be avoided safely. The authors have initiated controlled randomized trials in Cardiff and Edinburgh which have indicated that, provided that nodes are identified for histologic examination, simple mastectomy, node sampling, and selective radiotherapy give equal survival rates to routine radical treatment, whether this is by surgery or radiotherapy. Provided sampling of nodes is adequate and histologically proven, locoregional control also is satisfactory. A current randomized trial comparing this policy with Patey mastectomy has allowed comparative studies of axillary node status. These and follow-up data indicate that for a valid assessment, three to four nodes should be identified by the surgeon for histologic examination, the false negative rate being less than 10%.

Entities:  

Mesh:

Year:  1982        PMID: 7051998      PMCID: PMC1352620          DOI: 10.1097/00000658-198209000-00017

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  9 in total

1.  A controlled trial of conservative treatment for early breast cancer.

Authors:  A P Forrest; E N Gleave; M M Roberts; J M Henk; I H Gravelle
Journal:  Proc R Soc Med       Date:  1970-02

2.  Simple mastectomy and pectoral node biopsy.

Authors:  A P Forrest; M M Roberts; E Cant; A Shivas
Journal:  Br J Surg       Date:  1976-08       Impact factor: 6.939

3.  Lymph-node biopsy during simple mastectomy.

Authors:  E L Cant; A A Shivas; A P Forrest
Journal:  Lancet       Date:  1975-05-03       Impact factor: 79.321

Review 4.  Advances in the management of breast cancer: physician and surgeon.

Authors:  A P Forrest
Journal:  Scott Med J       Date:  1981-07       Impact factor: 0.729

5.  Manchester regional breast study. Preliminary results.

Authors:  J P Lythgoe
Journal:  Lancet       Date:  1978-04-08       Impact factor: 79.321

6.  Evaluation of treatment of primary cancer of the breast.

Authors:  A P Forrest
Journal:  Proc R Soc Med       Date:  1967-10

7.  A clinical trial in the management of operable cancer of the breast.

Authors:  A O Langlands; R J Prescott; T Hamilton
Journal:  Br J Surg       Date:  1980-03       Impact factor: 6.939

8.  Findings from NSABP Protocol No. B-04: comparison of radical mastectomy with alternative treatments. II. The clinical and biologic significance of medial-central breast cancers.

Authors:  B Fisher; N Wolmark; C Redmond; M Deutsch; E R Fisher
Journal:  Cancer       Date:  1981-10-15       Impact factor: 6.860

9.  New Edinburgh primary breast cancer trials.

Authors: 
Journal:  Br J Cancer       Date:  1975-11       Impact factor: 7.640

  9 in total
  9 in total

1.  A further survey of surgical management of the axilla in UK breast cancer patients.

Authors:  Ronan W Glynn; Linda Williams; J Michael Dixon
Journal:  Ann R Coll Surg Engl       Date:  2010-06-01       Impact factor: 1.891

2.  Axillary dissection in primary breast cancer.

Authors:  P J O'Dwyer
Journal:  BMJ       Date:  1991-02-16

3. 

Authors:  P Schäfer
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

Review 4.  Diagnosis of axillary lymph node metastases in patients with breast cancer.

Authors:  M Noguchi; N Katev; I Miyazaki
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Sentinel lymph node biopsy in staging small (up to 15 mm) breast carcinomas. Results from a European multi-institutional study.

Authors:  Gábor Cserni; Simonetta Bianchi; Vania Vezzosi; Riccardo Arisio; Rita Bori; Johannes L Peterse; Anna Sapino; Isabella Castellano; Maria Drijkoningen; Janina Kulka; Vincenzo Eusebi; Maria P Foschini; Jean-Pierre Bellocq; Cristi Marin; Sten Thorstenson; Isabel Amendoeira; Angelika Reiner-Concin; Thomas Decker; Manuela Lacerda; Paulo Figueiredo; Gábor Fejes
Journal:  Pathol Oncol Res       Date:  2007-03-27       Impact factor: 3.201

Review 6.  Axillary treatment for operable primary breast cancer.

Authors:  Nathan Bromham; Mia Schmidt-Hansen; Margaret Astin; Elise Hasler; Malcolm W Reed
Journal:  Cochrane Database Syst Rev       Date:  2017-01-04

7.  Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Authors:  I C Smith; K N Ogston; P Whitford; F W Smith; P Sharp; M Norton; I D Miller; A K Ah-See; S D Heys; J A Jibril; O Eremin
Journal:  Ann Surg       Date:  1998-08       Impact factor: 12.969

8.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer.

Authors:  A E Giuliano; D M Kirgan; J M Guenther; D L Morton
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

Review 9.  [Is axillary dissection in clinically lymph node-negative breast carcinoma further indicated?].

Authors:  F K Böhler; H Eiter; W Rhomberg
Journal:  Strahlenther Onkol       Date:  1998-12       Impact factor: 3.621

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.